Can Immunotherapy Cure FSGS

FSGS (Focal Segmental Glomerulosclerosis) is kind of serious pathological type in Nephrotic Syndrome. If treated ineffectively, it will progress into Renal Failure in several years after its diagnosis.

FSGS is an autoimmune disease, in which the immune system can not tell the differences between outside harmful stuffs and healthy kidney tissues and cells. As a result, the immune system attacks healthy kidney tissues and cells mistakenly thus resulting in inflammation in kidneys.

Kidney Transplant is still mainly adopted to treat FSGS when the kidneys fail. However, if the patients’ immune system is not regulated, it will attack the transplanted kidney again thus resulting in kidney damage. FSGS returns in more than 50% of patients who received kidney transplant.

With the development of regenerative medicine, Immunotherapy is applied to regenerate impaired tissues and organs. The successful application of Immunotherapy technology in treating kidney diseases brings infinite promise to patients with FSGS worldwide.

Immunotherapys are a group of undifferentiated cells with self-regeneration, immune-regulation, hematopoietic support differentiation features. They can differentiate into types of new cells with specialized function so they are called omnipotent cells.

Immunotherapys can differentiate into renal functional cells to form new kidney tissues. Meanwhile, Immunotherapy can stimulate the body to produce normal immune cells and suppress the abnormal proliferation of T cells thus rebuilding the immune system. Therefore, it can prevent the mistaken attack to kidneys.

The advantages of Immunotherapy in treating FSGS:

1. There are extensive sources of Immunotherapy and it is easy to be isolated, cultured and purified. After several times of proliferation, they still can remain the primary features of Immunotherapy.

2. The Immunotherapy have homing-ability. The injured organs, tissues etc release signals which can stimulate the Immunotherapy to travel injured sites automatically.

3. They are featured with immunological immaturity so they are not easy to be recognized by the receptors. Therefore, Immunotherapy does not need blood matching or cause rejection reaction at all.

4. The success rate of Immunotherapy can reach up to 85%.


However, Immunotherapy also has contraindications and some factors may affect its therapeutic result. If you are wondering to receive the therapy and want to know more information about it, it is free for you to consult us on line.